Skip to main content
Clinical Trials/NCT00561210
NCT00561210
Completed
Phase 4

Effect of Early Enteral Tube Feeding Nutrition With an Immune Enhancing Diet in Severe Burn Patients

Société des Produits Nestlé (SPN)5 sites in 1 country57 target enrollmentNovember 2003

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Infections on
Sponsor
Société des Produits Nestlé (SPN)
Enrollment
57
Locations
5
Primary Endpoint
Number of infections and number of multiple organ failure
Status
Completed
Last Updated
12 years ago

Overview

Brief Summary

Compare clinical and biological effects of two enteral tube feeding nutrition formula (immune enhancing diet versus polymeric diet)in severe burn hospitalized patients .

Registry
clinicaltrials.gov
Start Date
November 2003
End Date
March 2010
Last Updated
12 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Société des Produits Nestlé (SPN)
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Thermic burn from 20% to 80%
  • 15 \< age \< 70 years
  • written informed consent

Exclusion Criteria

  • diabetes mellitus
  • corticoid or immuno-suppressive therapy
  • evolutive cancers
  • pregnancy
  • abdominal lesion
  • hepatic or renal failure

Outcomes

Primary Outcomes

Number of infections and number of multiple organ failure

Time Frame: 6 months

Secondary Outcomes

  • digestive tolerance and healing(6 months)

Study Sites (5)

Loading locations...

Similar Trials